Heartseed Inc. announced that Takehiko Kaneko, M.D., Board Director and Chief Medical Officer (CMO), will speak at the ISSCR Boston International Symposium: PSC-Derived Therapies, to be held in Boston, USA, from December 11-12, 2025.

The symposium, themed "Accelerating PSC-Derived Cell Therapies: Starting with the End in Mind," brings together global pioneers leading the most advanced clinical trials. The program focuses on a unique philosophy that reverses the traditional "bench-to-bedside" approach, advocating instead for working backwards from patient needs to optimize the development of complex biological drug products.

Dr. Kaneko will speak in the session "Clinical Trials: Early Trials," discussing challenges and strategies in early-stage clinical development based on Heartseed's experience with its iPSC-derived cardiomyocyte therapy.

■ Presentation Overview

• Event: ISSCR Boston International Symposium: PSC-Derived Therapies
• Date: December 11-12, 2025
• Location: Boston, MA, USA
• Session: Clinical Trials: Early Trials
• Website: https://www.isscr.org/upcoming-programs/2025-boston-international-symposium